|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/10 | |
| A61K 47/38 | |||
| A61P 1/00 | |||
| A61P 1/10 |
| (11) | Number of the document | 2825188 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13713280.9 |
| Date of filing the European patent application | 2013-03-12 | |
| (97) | Date of publication of the European application | 2015-01-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/030551 |
| Date | 2013-03-12 |
| (87) | Number | WO 2013/138352 |
| Date | 2013-09-19 |
| (30) | Number | Date | Country code |
| 201213421769 | 2012-03-15 | US |
| (72) |
COMISKEY, Stephen, US
FENG, Rong, US
FOSS, John, US
SHAILUBHAI, Kunwar, US
|
| (73) |
Bausch Health Ireland Limited,
3013 Lake Drive Citywest Business Campus, Dublin 24,
IE
|
| (54) | FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE |
| FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE |